1 Min Read
Nov 22 (Reuters) - Strides Shasun Ltd
* Says receives USFDA approval for acetazolamide tablets
* Says product to be marketed by Strides Pharma Inc in the US market Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.